Association of genetic risk variants with attention-deficit/hyperactivity disorder trajectories in the general population

JAMA Psychiatry

Volumn 73, Issue 12, 2016, Pages 1285-1292

  Riglin, Lucy ^a   Collishaw, Stephan ^a   Thapar, Ajay K ^a   Dalsgaard, Søren ^b,c   Langley, Kate ^a,d   Smith, George Davey ^e   Stergiakouli, Evie ^e   Maughan, Barbara ^f   O'Donovan, Michael C ^a   Thapar, Anita ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b AARHUS UNIVERSITY   (Denmark)

^c Lundbeck Foundation Initiative for Integrative Psychiatric Research   (Denmark)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR; CHILD; COMORBIDITY; GENETIC RISK; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HUMAN; INTELLIGENCE QUOTIENT; INTERPERSONAL COMMUNICATION; LANGUAGE; MENTAL DISEASE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE CONTROL STUDY; COHORT ANALYSIS; CONDUCT DISORDER; ENGLAND; FEMALE; GENETIC LOAD; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; HEALTH SURVEY; LONGITUDINAL STUDY; MALE; MULTIFACTORIAL INHERITANCE; NEURODEVELOPMENTAL DISORDERS; POPULATION GENETICS; PRESCHOOL CHILD;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMORBIDITY; CONDUCT DISORDER; ENGLAND; FEMALE; GENETIC LOAD; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENETICS, POPULATION; HUMANS; LONGITUDINAL STUDIES; MALE; MULTIFACTORIAL INHERITANCE; NEURODEVELOPMENTAL DISORDERS; POPULATION SURVEILLANCE;

EID: 85011360845     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2016.2817     Document Type: Article

References (49)

1. Thapar A, Rutter M. Neurodevelopmental disorders. In: Thapar A, Pine DS, Leckman JF, Scott S, SnowlingMJ, Taylor E, eds. Rutter's Child and Adolescent Psychiatry. 6th ed. Oxford: Wiley Press; 2015.
2. Thapar A, Cooper M. Attention deficit hyperactivity disorder. Lancet. 2016;387(10024): 1240-1250.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
4. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: ameta-analysis of follow-up studies. Psychol Med. 2006;36(2):159-165.
5. Moffitt TE, Houts R, Asherson P, et al. Is adult ADHD a childhood-onset neurodevelopmental disorder? evidence from a four-decade longitudinal cohort study. Am J Psychiatry. 2015;172(10):967-977.
6. Agnew-Blais JC, Polanczyk GV, Danese A,Wertz J, Moffitt TE, Arseneault L. Evaluation of the persistence, remission, and emergence of attention-deficit/hyperactivity disorder in young adulthood. JAMA Psychiatry. 2016;73(7):713-720.
7. Caye A, Rocha TB, Anselmi L, et al. Attention-deficit/hyperactivity disorder trajectories from childhood to young adulthood: evidence from a birth cohort supporting a late-onset syndrome. JAMA Psychiatry. 2016;73(7):705-712.
8. Pingault JB, Viding E, Galéra C, et al. Genetic and environmental influences on the developmental course of attention-deficit/hyperactivity disorder symptoms from childhood to adolescence. JAMA Psychiatry. 2015;72(7):651-658.
9. Biederman J, Petty CR, Clarke A, Lomedico A, Faraone SV. Predictors of persistent ADHD: an 11-year follow-up study. J Psychiatr Res. 2011;45(2): 150-155.
10. Kessler RC, Adler LA, Barkley R, et al. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry. 2005;57(11):1442-1451.
11. Lara C, Fayyad J, de Graaf R, et al. Childhood predictors of adult attention-deficit/hyperactivity disorder: results from theWorld Health OrganizationWorld Mental Health Survey Initiative. Biol Psychiatry. 2009;65(1):46-54.
12. Shaw P, Malek M,Watson B, Greenstein D, de Rossi P, SharpW. Trajectories of cerebral cortical development in childhood and adolescence and adult attention-deficit/hyperactivity disorder. Biol Psychiatry. 2013;74(8):599-606.
13. Larsson H, Dilshad R, Lichtenstein P, Barker ED. Developmental trajectories of DSM-IV symptoms of attention-deficit/hyperactivity disorder: genetic effects, family risk and associated psychopathology. J Child Psychol Psychiatry. 2011;52(9):954-963.
14. Caye A, Spadini AV, Karam RG, et al. Predictors of persistence of ADHD into adulthood: A systematic review of the literature and meta-analysis [published online March 28, 2016]. Eur Child Adolesc Psychiatry.
15. Langley K, Fowler T, Ford T, et al. Adolescent clinical outcomes for young people with attention-deficit hyperactivity disorder. Br J Psychiatry. 2010;196(3):235-240.
16. Thapar A, Cooper M, Eyre O, Langley K. What have we learnt about the causes of ADHD? J Child Psychol Psychiatry. 2013;54(1):3-16.
17. Chang Z, Lichtenstein P, Asherson PJ, Larsson H. Developmental twin study of attention problems: high heritabilities throughout development. JAMA Psychiatry. 2013;70(3):311-318.
18. Franke B, Faraone SV, Asherson P, et al; International Multicentre Persistent ADHD Collaboration. The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol Psychiatry. 2012;17(10):960-987.
19. Larsson H, Asherson P, Chang Z, et al. Genetic and environmental influences on adult attention deficit hyperactivity disorder symptoms: A large Swedish population-based study of twins. Psychol Med. 2013;43(1):197-207.
20. Hamshere ML, Langley K, Martin J, et al. High loading of polygenic risk for ADHD in children with comorbid aggression. Am J Psychiatry. 2013;170(8): 909-916.
21. Martin J, Hamshere ML, Stergiakouli E, O'Donovan MC, Thapar A. Genetic risk for attention-deficit/hyperactivity disorder contributes to neurodevelopmental traits in the general population. Biol Psychiatry. 2014;76(8):664-671.
22. Groen-Blokhuis MM, Middeldorp CM, Kan KJ, et al. Attention-deficit/hyperactivity disorder polygenic risk scores predict attention problems in a population-based sample of children. J AmAcad Child Adolesc Psychiatry. 2014;53(10):1123-1129.e6.
23. Martin J, Hamshere ML, Stergiakouli E, O'Donovan MC, Thapar A. Neurocognitive abilities in the general population and composite genetic risk scores for attention-deficit hyperactivity disorder. J Child Psychol Psychiatry. 2015;56(6): 648-656.
24. Boyd A, Golding J, Macleod J, et al. Cohort profile: The 'children of the 90s'-the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol. 2013;42(1):111-127.
25. Fraser A, Macdonald-Wallis C, Tilling K, et al. Cohort profile: The Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int J Epidemiol. 2013;42(1):97-110.
26. Goodman R. The Strengths and Difficulties Questionnaire: A research note. J Child Psychol Psychiatry. 1997;38(5):581-586.
27. St Pourcain B, Mandy WP, Heron J, Golding J, Davey Smith G, Skuse DH. Links between co-occurring social-communication and hyperactive-inattentive trait trajectories. J AmAcad Child Adolesc Psychiatry. 2011;50(9):892-902.e5.
28. Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. Lancet. 2013; 381(9875):1371-1379.
29. Cross-Disorder Group of the Psychiatric Genomics Consortium. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45(9):984-994.
30. Neale BM, Medland SE, Ripke S, et al; Psychiatric GWAS Consortium: ADHD Subgroup. Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010;49(9):884-897.
31. Yang L, Neale BM, Liu L, et al; Psychiatric GWAS Consortium: ADHD Subgroup. Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. Am J Med Genet B Neuropsychiatr Genet. 2013;162B(5):419-430.
32. SchizophreniaWorking Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421-427.
33. Sklar P, Ripke S, Scott LJ, et al; Psychiatric GWAS Consortium Bipolar DisorderWorking Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4 [published correction appears in Nat Genet. 2012 Sep;44(9):1072]. Nat Genet. 2011;43 (10):977-983.
34. Ripke S,Wray NR, Lewis CM, et al; Major Depressive DisorderWorking Group of the Psychiatric GWAS Consortium. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry. 2013;18(4): 497-511.
35. Dudbridge F. Power and predictive accuracy of polygenic risk scores. PLoS Genet. 2013;9(3): e1003348.
36. Wechsler D, Golombok S, Rust J. WISC-III UK Wechsler Intelligence Scale for Children: UK Manual. Sidcup, UK: The Psychological Corporation; 1992.
37. Skuse DH, Mandy WP, Scourfield J. Measuring autistic traits: heritability, reliability and validity of the Social and Communication Disorders Checklist. Br J Psychiatry. 2005;187(6):568-572.
38. Bishop DV. Development of the Children's Communication Checklist (CCC): amethod for assessing qualitative aspects of communicative impairment in children. J Child Psychol Psychiatry. 1998;39(6):879-891.
39. Muthén LK, Muthén BO. Mplus User's Guide. 7th ed. Los Angeles, CA: Muthén & Muthén; 2012.
40. Muthén B, Muthén LK. Integrating person-centered and variable-centered analyses: growth mixture modeling with latent trajectory classes. Alcohol Clin Exp Res. 2000;24(6):882-891.
41. Asparouhouv T.Wald Test of Mean Equality for Potential Latent Class Predictors in Mixture Modeling: Technical Appendix. Los Angeles, CA: Muthén & Muthén; 2007.
42. Asparouhov T, Muthén B. Auxiliary variables in mixture modeling: three-step approaches using Mplus. Struct Equ Modeling. 2014;21(3):329-341. doi:10.1080/10705511.2014.915181
43. Heron JE, Croudace TJ, Barker ED, Tilling K. A comparison of approaches for assessing covariate effects in latent class analysis. Longit Life Course Stud. 2015;6(4):420-434. doi:10.14301/llcs.v6i4.322
44. Faraone SV, Biederman J, Monuteaux MC. Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder. Genet Epidemiol. 2000;18(1):1-16.
45. Larsson J-O, Larsson H, Lichtenstein P. Genetic and environmental contributions to stability and change of ADHD symptoms between 8 and 13 years of age: A longitudinal twin study. J AmAcad Child Adolesc Psychiatry. 2004;43(10):1267-1275.
46. Barnett K, Mercer SW, NorburyM,Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross-sectional study. Lancet. 2012;380(9836):37-43.
47. National Institute for Health and Care Excellence. Multimorbidity: clinical assessment and management. https://www.nice.org.uk/guidance/GID-CGWAVE0704/documents/draft-guideline. Accessed May 5, 2016.
48. Wolke D,Waylen A, SamaraM, et al. Selective drop-out in longitudinal studies and non-biased prediction of behaviour disorders. Br J Psychiatry. 2009;195(3):249-256.
49. Widaman KF. Missing data: what to do with or without them. Monogr Soc Res Child Dev. 2006;71 (3):42-64. doi:10.1111/j.1540-5834.2006.00404.x